These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 34493617)

  • 1. Monogenic Epilepsies: Disease Mechanisms, Clinical Phenotypes, and Targeted Therapies.
    Guerrini R; Balestrini S; Wirrell EC; Walker MC
    Neurology; 2021 Oct; 97(17):817-831. PubMed ID: 34493617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalized medicine in genetic epilepsies - possibilities, challenges, and new frontiers.
    Helbig I; Ellis CA
    Neuropharmacology; 2020 Aug; 172():107970. PubMed ID: 32413583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New paradigms for the treatment of pediatric monogenic epilepsies: Progressing toward precision medicine.
    Specchio N; Pietrafusa N; Perucca E; Cross JH
    Epilepsy Behav; 2022 Jun; 131(Pt B):107961. PubMed ID: 33867301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of genetic epilepsies: From empirical treatment to precision medicine.
    Striano P; Vari MS; Mazzocchetti C; Verrotti A; Zara F
    Pharmacol Res; 2016 May; 107():426-429. PubMed ID: 27080588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics of epilepsy.
    Pandolfo M
    Semin Neurol; 2011 Nov; 31(5):506-18. PubMed ID: 22266888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Landscape of Common Epilepsies: Advancing towards Precision in Treatment.
    Thakran S; Guin D; Singh P; Singh P; Kukal S; Rawat C; Yadav S; Kushwaha SS; Srivastava AK; Hasija Y; Saso L; Ramachandran S; Kukreti R
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized translational epilepsy research - Novel approaches and future perspectives: Part I: Clinical and network analysis approaches.
    Rosenow F; van Alphen N; Becker A; Chiocchetti A; Deichmann R; Deller T; Freiman T; Freitag CM; Gehrig J; Hermsen AM; Jedlicka P; Kell C; Klein KM; Knake S; Kullmann DM; Liebner S; Norwood BA; Omigie D; Plate K; Reif A; Reif PS; Reiss Y; Roeper J; Ronellenfitsch MW; Schorge S; Schratt G; Schwarzacher SW; Steinbach JP; Strzelczyk A; Triesch J; Wagner M; Walker MC; von Wegner F; Bauer S
    Epilepsy Behav; 2017 Nov; 76():13-18. PubMed ID: 28917501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Next-Generation Sequencing on the Diagnosis and Treatment of Epilepsy in Paediatric Patients.
    Mei D; Parrini E; Marini C; Guerrini R
    Mol Diagn Ther; 2017 Aug; 21(4):357-373. PubMed ID: 28197949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precision medicine in genetic epilepsies: break of dawn?
    Reif PS; Tsai MH; Helbig I; Rosenow F; Klein KM
    Expert Rev Neurother; 2017 Apr; 17(4):381-392. PubMed ID: 27781560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying mutations in epilepsy genes: Impact on treatment selection.
    Perucca P; Perucca E
    Epilepsy Res; 2019 May; 152():18-30. PubMed ID: 30870728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From Genetic Testing to Precision Medicine in Epilepsy.
    Striano P; Minassian BA
    Neurotherapeutics; 2020 Apr; 17(2):609-615. PubMed ID: 31981099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in epilepsy genetics.
    Orsini A; Zara F; Striano P
    Neurosci Lett; 2018 Feb; 667():4-9. PubMed ID: 28499889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From next-generation sequencing to targeted treatment of non-acquired epilepsies.
    Møller RS; Hammer TB; Rubboli G; Lemke JR; Johannesen KM
    Expert Rev Mol Diagn; 2019 Mar; 19(3):217-228. PubMed ID: 30661434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized translational epilepsy research - Novel approaches and future perspectives: Part II: Experimental and translational approaches.
    Bauer S; van Alphen N; Becker A; Chiocchetti A; Deichmann R; Deller T; Freiman T; Freitag CM; Gehrig J; Hermsen AM; Jedlicka P; Kell C; Klein KM; Knake S; Kullmann DM; Liebner S; Norwood BA; Omigie D; Plate K; Reif A; Reif PS; Reiss Y; Roeper J; Ronellenfitsch MW; Schorge S; Schratt G; Schwarzacher SW; Steinbach JP; Strzelczyk A; Triesch J; Wagner M; Walker MC; von Wegner F; Rosenow F
    Epilepsy Behav; 2017 Nov; 76():7-12. PubMed ID: 28917498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiological Biomarkers in Genetic Epilepsies.
    Armstrong C; Marsh ED
    Neurotherapeutics; 2021 Jul; 18(3):1458-1467. PubMed ID: 34642905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individualizing Treatment Approaches for Epileptic Patients with Glucose Transporter Type1 (GLUT-1) Deficiency.
    Daci A; Bozalija A; Jashari F; Krasniqi S
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29303961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent progress in the genetics of human epilepsies.
    Szepetowski P; Monaco AP
    Neurogenetics; 1998 Mar; 1(3):153-63. PubMed ID: 10737118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A roadmap for precision medicine in the epilepsies.
    EpiPM Consortium
    Lancet Neurol; 2015 Dec; 14(12):1219-28. PubMed ID: 26416172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Trial Design for Disease-Modifying Therapies for Genetic Epilepsies.
    Brock DC; Demarest S; Benke TA
    Neurotherapeutics; 2021 Jul; 18(3):1445-1457. PubMed ID: 34595733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene Therapy: Novel Approaches to Targeting Monogenic Epilepsies.
    Goodspeed K; Bailey RM; Prasad S; Sadhu C; Cardenas JA; Holmay M; Bilder DA; Minassian BA
    Front Neurol; 2022; 13():805007. PubMed ID: 35847198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.